What Is NAD+?
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell, essential for hundreds of metabolic reactions. It serves as an electron carrier in the mitochondrial electron transport chain and as a substrate for enzymes critical to DNA repair, gene expression, and cellular signaling.
The discovery that NAD+ levels decline significantly with age — and that this decline is causally linked to many hallmarks of aging — has made NAD+ restoration one of the most active areas of longevity research.
How NAD+ Declines With Age
By age 50, NAD+ levels are approximately 50% of what they were at age 20. This decline is driven by:
- Increased consumption: CD38 (which breaks down NAD+) increases with age and chronic inflammation
- Decreased synthesis: Rate-limiting enzymes in NAD+ biosynthesis become less efficient
- DNA damage accumulation: PARP enzymes consume more NAD+ to repair age-related DNA damage
- Chronic inflammation: Inflammatory signaling increases CD38 expression, creating a vicious cycle
NAD+ Precursors: NMN vs. NR
| Feature | NMN | NR | IV NAD+ |
|---|---|---|---|
| Full Name | Nicotinamide Mononucleotide | Nicotinamide Riboside | Intravenous NAD+ |
| Route | Oral | Oral | IV infusion |
| Steps to NAD+ | 1 (NMNAT converts NMN) | 2 (NRK then NMNAT) | Direct |
| Bioavailability | Good (Slc12a8 transporter) | Good (ENT transporters) | 100% |
| Clinical Trials | Multiple RCTs | Multiple RCTs | Limited |
| Cost | Moderate | Moderate | High |
Mechanisms: Why NAD+ Matters
Sirtuin Activation
Sirtuins (SIRT1-7) are NAD+-dependent deacetylases that regulate aging, metabolism, and stress resistance. When NAD+ declines, sirtuin activity decreases. Chu and Ghosh (2021) reviewed how reduced NAD+ levels are associated with aging and various diseases Chu & Ghosh, 2021.
DNA Repair (PARPs)
PARPs are the primary consumers of cellular NAD+. As DNA damage accumulates with age, PARPs consume more NAD+, leaving less for sirtuins and other critical processes.
Mitochondrial Function
NAD+ is essential for the electron transport chain. Declining NAD+ impairs mitochondrial function, reducing ATP production and increasing reactive oxygen species (ROS).
Clinical Evidence
NMN Clinical Trials
Yi et al. (2023) showed that NMN supplementation is safe at doses up to 900 mg/day, significantly increasing blood NAD+ and improving physical performance. The most effective dose was 600 mg/day Yi et al., 2023.
Katayoshi et al. (2023) found long-term NMN supplementation was safe in middle-aged and older adults Katayoshi et al., 2023.
NR Clinical Trials
Berven et al. (2023) demonstrated that high-dose NR (3000 mg/day) was well-tolerated in Parkinson’s disease patients, leading to a 5-fold increase in blood NAD+ Berven et al., 2023.
Comprehensive Review
Iqbal and Nakagawa (2024) found NAD+ precursor supplementation effectively elevates NAD+ levels and mitigates metabolic syndrome in animal studies, though clinical efficacy in humans is still limited Iqbal & Nakagawa, 2024.
Want expert guidance on dosing and protocols? Telegenix connects you with licensed clinicians who specialize in peptide therapy. Get started with a free consultation — no guesswork, just science-backed protocols.
Dosing Protocols
| Protocol | Compound | Dose | Frequency | Duration |
|---|---|---|---|---|
| General Longevity | NMN | 500-600 mg | Once daily (morning) | Ongoing |
| General Longevity | NR | 300-1000 mg | Once daily | Ongoing |
| Athletic Performance | NMN | 600-900 mg | Once daily (morning) | 8-12 weeks |
| Neurological Support | NR | 1000-3000 mg | Divided doses | Per clinical guidance |
| IV NAD+ Therapy | NAD+ | 250-500 mg | 1-2x per month | Per clinical guidance |
Looking for a supervised peptide or TRT protocol? The clinical team at Telegenix designs evidence-based protocols tailored to your biology. Book a free consultation and stop guessing.
NAD+ and Peptide Synergies
| Combination | Rationale |
|---|---|
| NAD+ + Epithalon | Telomere protection + cellular energy restoration |
| NAD+ + BPC-157 | Tissue repair + mitochondrial support |
| NAD+ + CJC-1295/Ipamorelin | GH optimization + metabolic enhancement |
| NAD+ + Selank | Neuroprotection + cognitive support |
Key Takeaways
NAD+ therapy represents one of the most evidence-based approaches to addressing age-related decline at the cellular level. Both NMN and NR have demonstrated safety and efficacy in raising NAD+ levels in human clinical trials. While longevity benefits seen in animal models are compelling, long-term human outcome data is still accumulating.
References
- Iqbal T, Nakagawa T. Biochem Biophys Res Commun. 2024;702:149590. PubMed
- Berven H, et al. Nat Commun. 2023;14(1):7793. PubMed
- Yi L, et al. Geroscience. 2023;45(1):29-43. PMC
- Katayoshi T, et al. Sci Rep. 2023;13(1):2786. Link
- Chu X, Ghosh S. Exp Biol Med. 2021;246(24):2543-2552. PMC
Explore Related Peptides on OnlinePeptideDoctor.com
- Epithalon: Telomere Anti-Aging [blocked] — Pair NAD+ with telomere protection
- GHK-Cu: Multi-System Repair [blocked] — Anti-aging copper peptide
- CJC-1295 + Ipamorelin: GH Stack [blocked] — Growth hormone for metabolic health
- Selank: Neuroprotective Peptide [blocked] — Brain health and cognitive support
- Browse All Peptide Articles [blocked] — 80+ research-backed articles
Disclaimer: This article is for educational and informational purposes only. It is not medical advice. Consult a qualified healthcare provider before starting any NAD+ supplementation protocol.
